Insider Trading News

Olema Prescribed drugs director sells shares price $147,955

SAN FRANCISCO—Harmon Cyrus, a director at Olema Prescribed drugs, Inc. (NASDAQ:OLMA), a $493.56 million market cap biotech firm, lately executed…

2 months ago

C3.ai CFO Lath Hitesh sells $476,238 in inventory

REDWOOD CITY, Calif.—Lath Hitesh, the Chief Monetary Officer of C3.ai, Inc. (NYSE:AI), not too long ago offered a good portion…

2 months ago

Paysign CEO Mark Newcomer sells $323,660 in inventory

Mark Newcomer, CEO of Paysign Inc. (NASDAQ:PAYS), has offered a good portion of his shares within the firm, in accordance…

2 months ago

Mark Zuckerberg sells Meta shares price $14.5 million

Mark Zuckerberg, Chairman and CEO of Meta Platforms Inc. (NASDAQ:META), which has seen its inventory surge practically 80% year-to-date and…

2 months ago

Docusign director Daniel Springer sells $56.4 million in inventory

Daniel D. Springer, a director at DocuSign Inc . (NASDAQ:DOCU), lately executed a collection of inventory transactions, in accordance with…

2 months ago

Mark Zuckerberg sells $7.97m in Meta Platforms inventory

Mark Zuckerberg, the Chairman and CEO of Meta Platforms, Inc. (NASDAQ:META), just lately offered a good portion of his Class…

2 months ago

Meta CEO Mark Zuckerberg sells shares price $14.2 million

Mark Zuckerberg, CEO and Chairman of Meta Platforms Inc. (NASDAQ:META), executed a sequence of inventory gross sales on December 10,…

2 months ago

Mark Zuckerberg sells $14.1 million in Meta Platforms inventory

Mark Zuckerberg, the Chairman and CEO of Meta Platforms, Inc. (NASDAQ:META), has bought a good portion of his holdings within…

2 months ago

P10, inc. sees vital inventory sale by main stakeholders totaling $5.59 million

DALLAS—P10, Inc. (NASDAQ:PX), an funding agency with a market capitalization of $1.48 billion and robust momentum exhibiting a 70% value…

2 months ago

Dyne therapeutics SVP Richard Scalzo sells $40,914 in inventory

Richard Scalzo, Senior Vice President and Head of Finance & Admin at Dyne Therapeutics, Inc. (NASDAQ:DYN), just lately bought shares…

2 months ago